












Joey Azofeifa
Founder at Arpeggio Bio
Joey Azofeifa was the founder of Arpeggio Bio which went through YC in S19. Arpeggio Bio is a pioneering pharmaceutical company that develops drugs targeting transcription factors using AI and high-throughput RNA-sequencing. With $20M in venture funding, we've targeted "undruggable" proteins like NRF2, TEAD, and GPX4 where our lead program is rapidly progressing towards a DC for the treatment of IO-resistant melanoma.
Follow Joey
Previously at

Merck

Forma Therapeutics
Boulder BioConsulting

Boulder Bioconsulting, Inc.
Alumnus of

University of Colorado Boulder
University of Colorado - Boulder

Vassar College